Loading clinical trials...
Loading clinical trials...
This study will evaluate the superiority of ulipristal acetate versus placebo for the treatment of abnormal uterine bleeding associated with uterine fibroids
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
NCT00050752 · Renal Tumor Histology, Cutaneous Leiomyoma, and more
NCT06405997 · Sporadic Lymphangioleiomyomatosis, TSC-associated Lymphangioleiomyomatosis
NCT05500118 · Leiomyoma, Uterine, High-Intensity Focused Ultrasound Ablation, and more
NCT07474688 · Uterine Fibroids (Leiomyoma)
NCT01552434 · Advanced Malignant Neoplasm, Castleman Disease, and more
Watson Investigational Site 125
Tucson, Arizona
Watson Investigational Site 102
San Diego, California
Watson Investigational Site 112
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions